Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05456685
Title IMGN853 With Carboplatin in Second-line Treatment of FRalpha Expressing, Platinum-sensitive Epithelial Ovarian Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors ImmunoGen, Inc.
Age Groups: adult | senior
Covered Countries USA | GBR | ESP | CAN | BEL

No variant requirements are available.